Famotidine and other acid-lowering medicines are alternatives to ranitidine for heartburn, according to the article. The OncoDaily article reviews ranitidine, an acid-lowering drug, and other treatment options. It covers people with Acid Reflux / GERD, stomach ulcers, and related problems. This is an overview, not a new study testing treatments in people. One useful detail is the drug name behind the brand. The article lists famotidine under both Pepcid and Zantac 360. Zantac 360 contains famotidine, not ranitidine. That distinction matters when comparing medicine labels or sharing past experiences. Famotidine reduces stomach acid in a similar way to ranitidine. The article also lists cimetidine and nizatidine as alternatives. It notes that cimetidine has more potential to interact with other medicines. Another option is Proton Pump Inhibitors, medicines that reduce stomach acid more strongly and for longer. Examples include omeprazole and pantoprazole. The article says these are generally preferred for frequent symptoms and acid-related damage to the food pipe. They are more effective at healing that damage. Although the article's title asks about cancer, the supplied excerpt gives no cancer-risk figures. It also provides no treatment success rates or study size. It cannot settle how much ranitidine might change cancer risk. For BioSocial members, the practical takeaway is clearer tracking, not a medicine switch. Recording the exact drug name alongside weekly symptom days can make comparisons more useful. Notes about symptom strength and timing can add context. Community experiences can reveal differences without proving which medicine caused them. What medicine names and symptom patterns have you recorded over time?